TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TIL

Instil Bio Inc.

Healthcare · Biotechnology

7.20$ -0.3% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Instil Bio Inc. (TIL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 53.4% of the shares are freely tradable; institutional investors hold 62.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 62.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 6.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 53.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 7Mio.

Largest Shareholders

Institutions

Institutions TIL
Name Stake (%) Shares Change (%) Date
BML Capital Management LLC 9.52 645,600 +0.0 06/30/2026
Cpmg Inc 6.06 410,922 +0.0 03/31/2026
Kalehua Capital Management LLC 4.76 322,879 +0.0 03/31/2026
Vivo Capital, LLC 4.32 292,743 +0.0 06/30/2026
Vanguard Capital Management, LLC 2.57 174,583 +0.0 03/31/2026
Millennium Management LLC 1.98 134,575 +1.2 06/30/2026
Renaissance Technologies Corp 0.87 59,100 -12.8 03/31/2026
BlackRock Inc 0.77 52,018 +1.6 03/31/2026
Delaware Management Holdings Inc 0.74 50,000 +0.0 03/31/2026

Funds

Funds TIL
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.75 118,992 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?